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Volatile metabolomic signature of 
human breast cancer cell lines
Catarina L. Silva1, Rosa Perestrelo1, Pedro Silva1, Helena Tomás1,2 & José S. Câmara1,2
Breast cancer (BC) remains the most prevalent oncologic pathology in women, causing huge 
psychological, economic and social impacts on our society. Currently, the available diagnostic tools 
have limited sensitivity and specificity. Metabolome analysis has emerged as a powerful tool for 
obtaining information about the biological processes that occur in organisms, and is a useful platform 
for discovering new biomarkers or make disease diagnosis using different biofluids. Volatile organic 
compounds (VOCs) from the headspace of cultured BC cells and normal human mammary epithelial 
cells, were collected by headspace solid-phase microextraction (HS-SPME) and analyzed by gas 
chromatography combined with mass spectrometry (GC–MS), thus defining a volatile metabolomic 
signature. 2-Pentanone, 2-heptanone, 3-methyl-3-buten-1-ol, ethyl acetate, ethyl propanoate and 
2-methyl butanoate were detected only in cultured BC cell lines. Multivariate statistical methods were 
used to verify the volatomic differences between BC cell lines and normal cells in order to find a set of 
specific VOCs that could be associated with BC, providing comprehensive insight into VOCs as potential 
cancer biomarkers. The establishment of the volatile fingerprint of BC cell lines presents a powerful 
approach to find endogenous VOCs that could be used to improve the BC diagnostic tools and explore 
the associated metabolomic pathways.
Although there has been a sustained decline in mortality rates over recent decades, breast cancer (BC) continues 
to be the most prevalent malignancy among women worldwide and is a major cause of female deaths. A number 
of associated factors, including age, gender, ethnicity, lifestyle (tobacco, alcohol, diet, and lack of exercise) and 
genetics, such as mutations in the tumor suppressor genes BRCA1 (mutation on chromosome 17) and BRCA2 
(mutation on chromosome 13), have been identified as the most common inherited causes of susceptibility to BC. 
The BRCA1 and BRCA2 genes encode very large proteins that are expressed in a wide variety of different tissues 
and are implicated in processes such as DNA repair and recombination, checkpoint control of the cell cycle, and 
transcription. Families with a high incidence of BC may carry mutations in one or both of these genes, or alterna-
tively, members of these families may have similar lifestyle habits and may have been affected by similar environ-
mental factors1,2. Furthermore, other important gene mutations related to BC development include mutations in 
ATM (ataxia-telangiectasia mutated), TP53 (tumor protein p53), and PTEN (phosphatase and tensin homolog 
deleted on chromosome ten)3–5. Most of these are rare and often do not increase the risk of BC as much as do 
mutations in the BRCA genes. Detection of BC at an early stage is extremely important to reduce the burden of 
disease because earlier detection leads to better patient outcomes, as metastatic states are avoided6,7. Currently, 
there is no single screening test that is totally reliable, and a number of tests can be combined to help detect early 
stage BC. Current screening techniques include self-examination for lumps or nodes, mammography, ultrasound, 
magnetic resonance imaging and biopsy using a fine needle or similar instrument to aspirate or otherwise remove 
a sample of fluid or cells from any suspicious lump or node for microscopic examination8. These methods are 
generally invasive, time-consuming and require special medical skills. Therefore, there is a need for non-invasive, 
accurate and rapid screening tests for early detection. In this context, it is useful to identify volatile organic com-
pounds (VOCs) that may prevent or predict the occurrence of metastasis before it manifests in the patient.
Metabolomics has emerged as a powerful tool for understanding biological processes that occur in humans, 
and it has mostly been based on the analysis of biofluids, such as blood, saliva, or urine, to discover new cancer 
biomarkers or to diagnose a disease9.
The use of cell culture metabolomics enables both the discovery of novel biomarkers of pathological con-
ditions and investigation of the related metabolomic pathways (Fig. 1). Many of the metabolic processes in the 
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body, such as lipid peroxidation, energy metabolism through glycolysis and amino acid catabolism are common 
to all living cells9. It is believed that some metabolic pathways might be up- or down-regulated in cancer cells and, 
therefore, metabolome analysis may reveal differences between biological samples based on metabolic profiles or 
fingerprints. Indeed, cancer cells have an altered metabolism compared with normal cells that may lead to the pro-
duction of specific compounds10. In recent years, several studies have reported the analysis of cancerous cell lines 
to find potential cancer biomarkers11–14. The most recent techniques include the use of nanomaterial-based sen-
sors11, electrochemical sensors15, or thermal desorption coupled with gas chromatography mass spectrometry16. 
However, most of these techniques are expensive and time-consuming. In this work, solid-phase microextraction 
in headspace mode (HS-SPME), which was developed by the Pawliszyn group17 in the early 90’s and consists of a 
fiber coated with different polymers extracting a wide range of chemical compounds, was selected as an extrac-
tion technique. This technique is superior to other extraction techniques, in that it is rapid, easy to use, sensitive 
and does not require a concentration step before analysis.
In this study, a comparative analysis of the volatile metabolomic signature of BC cell lines (T-47D, 
MDA-MB-231, MCF-7) and normal human mammary epithelial cells (HMEC), was carried out, in order to iden-
tify BC-specific VOCs and to identify a set of biomarkers that could hopefully be correlated with VOCs released 
in vivo by BC cells. This finding will improve the knowledge about the origin of VOCs and providing compre-
hensive information as potential BC biomarkers. This strategy can help reveal novel BC biomarkers that might 
expand the current understanding of this multi-factorial disease. The GC–qMS analyses allow specific identifica-
tion of VOCs, while multivariate statistical analysis is able to differentiate and discriminate oncologic from nor-
mal cells providing proof-of-principle for the detection of different volatile metabolomic patterns in target cells.
Results and Discussion
VOCs associated with normal breast cells (HMEC) and BC cell lines (T-47D, MDA-MB-231 and MCF-7 cells) 
were investigated. The cell lines for the present study were chosen based on their different molecular character-
istics (Supplementary Table S1): namely, the expression of the estrogen receptor (ER), the progesterone receptor 
(PR), and the human epidermal growth factor receptor 2 (HER2). It is well known that BC is heterogeneous and 
that its prognosis and treatment depends on the molecular subtype of the cancer cells. The VOCs arising from 
the cellular metabolism were studied using HS-SPME/GC-MS: (a) by direct analysis of the headspace of the cul-
ture flasks after cell growth (these results are hereinafter designated as “Cells”); and (b) by analysis of the volatile 
metabolites from the culture media at different pH values. From the analysis of chromatograms, it was possible 
to identify 60 VOCs belonging to distinct chemical groups, namely, alkanes, aldehydes, ketones, acids, alcohols 
and benzene derivatives.
VOC signature of BC cell lines and breast normal cells. We identified twenty-six VOCs belonging 
to several chemical groups (Fig. 2): namely, alkanes, aldehydes, ketones, acids, alcohols and benzene derivatives 
(Table 1).
From these VOCs, 13 were found to be common in all studied breast cells (both normal and cancerous), 5 
were present only in normal breast cells (HMEC), and 2 compounds were identified only in the MCF-7 breast 
cell line.
As can be observed in Fig. 2, the MCF-7 cell line demonstrated the most complex volatile metabolomic sig-
nature in terms of number of the identified VOCs and total GC peak areas compared with the other cell lines. 
Moreover, for all BC cell lines, the major chemical group identified was the higher alcohols, represented mainly 
by 2-ethyl-1-hexanol and cyclohexanol. These VOCs have already been reported in previous studies using BC 
cell lines18,19 and in urine20,21 from cancer patients. It is believed that their endogenous origin is as hydrocarbon 
Figure 1. Formation of some intermediate products of lipid peroxidation. Adapted from ref. 22 .
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metabolism byproducts22,23. The obtained data indicated that the levels of both VOCs (2-ethyl-1-hexanol and 
cyclohexanol) were higher in all investigated BC cells than in normal cells (HMEC). This might be due to the 
production of lipid peroxidation biomarkers with hydroxylase that are mediated by cytochrome P45012,18.
Similar results were reported by Peled and collaborators24 when studying genetic mutations in lung cancer 
cells, and by Davies and collaborators25, who compared the volatile profile from the headspace of lung cancer cells 
with genetic mutations in TP53 and KRAS. Most of the identified VOCs were common to all BC cell lines and 
normal human mammary epithelial cells, but six of them, 2-pentanone, 2-heptanone, 3-methyl-3-buten-1-ol, 
ethyl acetate, ethyl propanoate, and 2-methyl butanoate, were detected only in BC cell lines. This finding justifies 
a more detailed investigation to evaluate of these six VOCs as BC biomarkers.
The influence of pH on the VOCs identified from culture media. The pH is one of the parame-
ters that influences the extraction efficiency of VOCs and therefore it is required an optimization step. This was 
accomplished by the assessment of volatiles from culture media at different pH. We evaluated the effect of pH on 
the volatile signature obtained from culture media. At pH 2, the MCF-7 cells had the highest total GC peak area 
with acids (hexanoic acid, octanoic acid and 2-ethyl-hexanoic acid) being the most dominant chemical group. 
Figure 2. Distribution of VOCs identified in cultured breast cell lines. 
Peak no.
RT 
(min) Abbreviation Ion VOC
HMEC 
(×105)
T-47D 
(×105)
MDA-MB-231 
(×105)
MCF-7 
(×105)
2 4.356 HEXA 57 hexane 0.44 — — —
4 5.127 M4HEPT 43, 70 4-methyl-heptane 4.83 — — —
5 5.739 ACTONE 43, 58 acetone 9.24 501.87 10.82 22.00
6 6.843 ETHATE 43, 61 ethyl acetate — 8.56 3.16 25.55
8 8.716 ETHPPATE 57, 44 ethyl propanoate — 18.11 2.17 19.66
9 9.337 PENTONE2 43, 86 2-pentanone — — — 22.74
10 9.994 DECA 57, 44 decane 3.36 354.35 4.28 12.80
12 12.341 M2BTATE 57 2-methyl butanoate — 12.83 — 13.88
17 15.865 ETHBNZ 91, 106 ethylbenzene 12.1 4.02 2.38 10.23
18 16.646 DMBNZ13 91, 106 1,3-dimethylbenzene 6.32 3.81 2.30 5.23
19 17.395 BUTOL1 56, 41 1-butanol 1.21 2.84 2.88 5.94
20 19.379 HPTONE2 43, 58 2-heptanone — 4.96 16.46 40.00
22 20.157 DODEC 57, 43, 71 dodecane 14.19 21.29 19.93 54.42
25 23.765 M33BUTOL1 41, 56 3-methyl-3-buten-1-ol — — — 3.93
26 24.155 STYENE 104, 78 styrene 64.50 139.81 39.93 125.93
27 25.511 TMBNZ124 105 1,2,4-trimethylbenzene 3.88 — — 3.92
29 26.207 CHEXONE 55, 42, 98 cyclohexanone 2.11 20.23 12.83 8.99
32 33.450 TTDECANE 57 tetradecane 21.92 — — —
33 33.598 CHEXOL 57, 82 cyclohexanol — 99.42 74.31 210.4
34 35.176 B13DMEBNZ 175, 190 1,3-bis(1,1-dimethylethyl)-benzene 4.56 9.42 7.22 31.67
36 39.305 E2HEXOL1 57, 43 2-ethyl-1-hexanol 28.32 950.78 184.81 1803.82
38 41.341 BNZAL 106, 77 benzaldehyde 2.81 — — —
45 48.761 ACTPONE 105, 77 acetophenone 4.44 — — —
47 53.752 NPTENE 128 naphthalene 3.60 3.80 3.70 5.61
54 70.775 PHOL 94 phenol 3.93 3.35 3.96 5.48
60 79.610 DT24BPHOL 191 2,4-di-tert-butylphenol 51.57 73.53 71.04 160.00
Table 1. Identification of VOCs from investigated human mammary epithelial cells and human BC cell 
lines by HS-SPME/GC-MS.
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Aldehydes (benzaldehyde and 3,4-dimethyl-benzaldehyde) were the most predominant chemical group in the 
T-47D and MDA-MB-231 cells (Fig. 3; Supplementary Table S2). At pH 7, for MCF-7 cells, alkanes, ketones and 
alcohols were found the dominant chemical groups, which were represented by dodecane, 2-heptanone, and 
2-ethyl-1-hexanol. For the other breast target cells alcohols (cyclohexanol) were the most representative chemical 
group. Finally, at pH 10 the main chemical group identified for MCF-7 cells were alkanes, ketones and alcohols 
(2-ethoxy-2-methyl-propane, acetone and 2-ethyl-1-hexanol). For T-47D and MDA-MB-231 cells, alcohols rep-
resented by cyclohexanol, presented the major contribution. As previously mentioned, it is believed that cancer 
cells have altered metabolisms leading to different volatile metabolomic patterns. This was observed in our study, 
where we identified some differences between BC cell lines and normal cells (Supplementary Table S2). Several 
VOCs were found to be common in all breast cell lines for all conditions, including, 2-ethoxy-2-methyl-propane, 
acetone, 2-methyl-2-propanol, cyclohexanol, 1,3-bis(1,1-dimethylethyl)-benzene and 2-ethyl-1-hexanol which 
had higher levels in BC cells. Ethyl acetate was only present in the T-47D cell line (Supplementary Table S2). 
Kwak and collaborators26 described a similar study using melanoma cells and identified higher concentrations 
of acetone in cancer cells. The metabolomic origin of most VOCs is still unknown, as they rely on a variety 
of endogenous pathways and exogenous sources. Huang and collaborators18 reported that cyclohexanol and 
2-ethyl-1-hexanol had lower concentrations in BC cells and suggested that they were generated by endogenous 
hydrocarbon metabolism. Hydrocarbons can be metabolized to aldehydes or ketones in the body via alcohol dehy-
drogenase (ADH) and cytochrome P450 activities12. The higher activity of cytochrome P450 may explain why 
BC cell lines have less cyclohexanol than normal breast cells18. It can also induce a variety of biological responses, 
including the biotransformation of alkanes, alkenes and aromatic compounds27. Furthermore, Philips et al.  
suggested that breast diseases are associated with increases in oxidative stress and a higher activity of P45028. 
Nevertheless, 2-ethyl-1-hexanol was found at higher levels in BC cells than in to normal cells. According to the 
human metabolome database, 2-ethyl-1-hexanol is involved in cell signaling, membrane integrity/stability and 
energy storage and it was also detected in lung cancer cell lines16 at increased levels when compared with the 
medium. At pH 10, the levels for most of the VOCs were higher in BC cells than in normal breast cells, including 
those of acetone, 2-pentanone, cyclohexanol, 2-ethyl-1-hexanol and acetophenone.
PCA and PLS-DA analyses of VOCs. To verify the significance of the identified VOCs from the head-
spaces of the culture flasks and the cell culture media at different pH conditions, a one-way ANOVA test was 
applied to analyze the data matrix. From the identified VOCs, a total of 23 (from cultured flask headspace), 52 
(from culture media at pH 2), 34 (from the culture media at pH 7) and 43 (from the culture media at pH 10) 
showed significant differences (p < 0.05) (Supplementary Fig. S1).
Principal component analysis (PCA) was performed for each condition to identify variables to differentiate 
the VOCs pattern of the HMEC cells from those of the BC cell lines (MCF-7, T-47D and MDA-MB-231 cells), 
and from the VOCs patterns obtained from the culture media at different pH values (Fig. 4). The statistical data 
summary of PCAs are described in Supplementary Table S3. The differentiation between the above conditions 
was shown as the loading scores plot of the two principal components of the PCA. The PCA analysis is an unsu-
pervised projection method used to visualize the dataset that displays the similarities and differences between 
groups and, in this case, demonstrated that the variables (scaled by standard deviation) used were sufficient to 
describe subsets with similar characteristics.
These results demonstrated that the scores from the cancer cell lines and those from the normal breast cells 
exhibited separate trends in the plots. Figure 4A shows the loading scatterplots of the PCA obtained from the 
analysis of the VOCs in the headspace of cultured flasks. It can be observed that 3 groups were formed, where 
HMEC cells was clearly differentiated from BC cell lines, which showed greater differentiation from MCF-7 cell 
lines across the PC1 and from T-47D and MDA-MB-231 across the PC2. Interestingly, BC cell lines formed two 
separated groups according molecular subtype (luminal A versus triple negative). However, no differentiation was 
achieved between T-47D and MDA-MB-231 cell lines, which formed a single group, perhaps this grouping of the two 
cell lines might be due to the fact that they have similar molecular characteristics. The variables that explain the differ-
entiation between cell lines are represented in Fig. 4B. The PCs values of MCF-7 cell lines were influenced by most of 
variables used in this test. On the other hand, PCs values of T-47D and MDA-MB-231 cell lines were highly influenced 
by cyclohexanone, 1,2,4-trimethylbenzene, ethylbenzene and 1,3-dimethylbenzene for PC1, and by cyclohexanone for 
PC2. The HMEC cells were influenced by 4-methyl-heptane, tetradecane, benzaldehyde and acetophenone for PC1 
values, and by 1,2,4-trimethylbenzene, ethylbenzene, 1,3-dimethylbenzene and phenol for PC2 values.
Figure 3. Distribution by chemical families of VOCs identified in culture media at different pH conditions 
of breast cell lines. 
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Concerning the other tested conditions, the loading scatterplots of the PCA obtained from the analysis of 
VOCs from cell culture media at pH 2, pH 7 and pH 10, and respective influence of variables, are showed in 
Supplementary Fig. S2. Surprisingly, four groups were formed encompassing all breast cell lines in study under 
pH 2 and pH 7, where MCF-7 was differentiated from other cell lines mainly across PC1, while HMEC, T-47D 
and MDA-MB-231 were differentiated from each other through PC2.
Under pH 10, the pattern of differentiation between cell lines is similar to obtained for headspace, in which 3 
groups (HMEC, T-47D/MDA-MB-231 and MCF-7) were formed. The differentiation between cell lines obtained 
under pH 2 and pH 7 may be due to the alterations of molecular components released under more acidic con-
ditions than those normally present in the culture medium (pH 7.3). However, for differentiation and discrim-
ination between normal breast cell lines and oncological breast cell lines based on the VOCs emitted as close 
to reality as possible in human cell tissues, partial least squares analysis (PLS) and linear discriminant analysis 
(LDA) were performed only with data from headspace of cell cultures. The statistical data summary of PLS and 
LDA are described in Supplementary Tables S5 and S6, respectively. Sample classification by PLS showed that the 
differentiation between cell lines was explained through one single component. PLS loading lineplot are presented 
in Fig. 5, which can be observed four centroids corresponding to each cell lines.
Similar to obtained in the PCA, HMEC centroid was clearly differentiated from oncologic breast cell lines, and 
MCF-7 (triple negative type) was distinguished from two luminal A type cell lines. On the other hand, T-47D and 
MDA-MB-231 remain very close to each other, which PLS values was 0.0588 and 0.0037, respectively. Regarding 
the influence of variables on PLS values of cell lines, HMEC was highly influenced by 4-methyl-heptane, tet-
radecane, benzaldehyde and acetophenone, T-47D and MDA-MB-231 were influenced by cyclohexanone, 
1,2,4-trimethylbenzene, ethylbenzene and 1,3-dimethylbenzene, and MCF-7 was influenced by the remaining 
VOCs.
The linear discriminant analysis (LDA) was applied as a supervised pattern recognition method in order to 
discriminate statistically the cell lines under study, where samples were grouped according to molecular type as 
follows: N (HMEC), BL (T-47D and MDA-MB-231) and BTN (MCF-7). The LDA scatterplot of cell lines classifi-
cation according to canonical functions were showed in Fig. 6.
The cell lines samples formed three clearly defined groups with a classification rate of 100%. Recognition abil-
ity, calculated as the percentage of members of the data set that were correctly classified, and prediction ability, 
Figure 4. (A) Separation of breast cancer cell lines and normal cells based on PCA scores scatter plot and 
(B) Line plot of principal component values obtained using selected compounds by significance of one-way 
ANOVA (p < 0.05) obtained from the analysis of 4 types of breast cell lines.
Figure 5. (A) Partial Least Square Analysis (PLS) scatter plot and (B) Line plot of selected compounds by 
significance of one-way ANOVA (p < 0.05) obtained from the analysis of 4 types of breast cell lines using 
cultured headspace analysis.
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calculated as the percentage of members that were correctly classified, were 100% in all cases. After applying 
LDA with backward removal (p < 0.05) of variables, only two VOCs proved to be significant for discrimination 
between three defined previously, namely 1,2,4-trimethylbenzene and benzaldehyde. These compounds have 
been already identified in cancer cell studies by Brunner et al.29 using PTR-MS, by Filipiak et al.16 in lung cancer 
cells and Mochalski et al.30 with human hepatocellular carcinoma cells where it was observed an increase in the 
release of this compound. Moreover, these two VOCs appear to be promise biomarkers due to fact that achieve a 
successful discriminant classification of samples according to molecular type of breast cell lines, demonstrating 
that volatile metabolomic signature of breast cells can be a useful approach to identify potential BC biomarkers 
for early diagnosis of BC.
Conclusions
This study demonstrated that HS-SPME/GC-MS is a simple, rapid, sensitive and solvent-free method that can 
be used to establish the volatile metabolomic patterns of normal and cancer breast cells. In addition, this study 
showed the potential of screening the in vitro VOCs associated with BC to identify potential volatile biomarkers 
to be used in early diagnosis. The headspace of culture media of normal and cancer cell lines was analyzed at 
different pH conditions. Sixty VOCs were identified as belonging to several chemical groups: namely, alkanes, 
aldehydes, ketones, acids, alcohols and benzene derivatives. Most of the identified VOCs are common to all BC 
cell lines and normal human mammary epithelial cells, but six of them, 2-pentanone, 2-heptanone, 3-methyl-
3-buten-1-ol, ethyl acetate, ethyl propanoate, and 2-methyl butanoate, were detected only in the headspace of 
cancer cell lines. Multivariate statistical data obtained in this study revealed that combining in vitro assays with 
HS-SPME/GC-MS is a useful strategy to differentiate and discriminate the volatile metabolomic signature of nor-
mal cells and BC cell lines according to molecular type, thus contributing to the discovery of novel biomarkers of 
BC and investigations of the related metabolomic pathways, and thereby improving the diagnostic tools for BC.
Methods
Materials and reagents. Phosphate buffer saline (PBS) was purchased from Sigma-Aldrich (St. Louis, MO, 
USA), sodium chloride was obtained from Panreac (Barcelona, Spain), the SPME holder for manual sampling of 
SPME fiber [50/30 μ m divinylbenzene/carboxen/polydimethylsiloxane (DVB/CAR/PDMS)] and the glass vials 
were purchased from Supelco (Bellefonte, PA, USA). The SPME fiber was conditioned according to manufactur-
er’s instructions. Before each daily analysis, the fiber was conditioned for 10 min in the injector port to prevent 
carryover. T75 glass flasks were purchased from Ningbo (Ja-Hely Technology, China).
Cell lines and cultivation conditions. The human breast adenocarcinoma cell line MCF-7 and human 
breast carcinoma cell lines T-47D and MDA-MB-231 were purchased from the Leibniz Institute DSMZ-German 
Collection of Microorganisms and Cell Cultures (Braunschweig, Germany). MCF-7 was grown in 90% RPMI 
1640 (Life technologies, Gibco® ) supplemented with 15% fetal bovine serum (FBS, Life technologies, Gibco® ), 
1% Antibiotic-Antimycotic solution (AA, Life technologies, Gibco® ), 1% MEM Non-Essential Amino Acids solu-
tion (Life technologies, Gibco® ), 1 mM sodium pyruvate (Sigma-Aldrich, St. Louis, MO, USA) and 10 μ g/mL 
human insulin (Sigma-Aldrich, St. Louis, MO, USA); T-47D cell line was grown in 85% RPMI 1640 supple-
mented with 15% fetal bovine serum (FBS), 1% Antibiotic-Antimycotic solution and 10 μ g/mL human insulin, 
while the MDA-MB-231 cell line was grown in 85% RPMI 1640 supplemented with 15% fetal bovine serum 
(FBS) and 1% Antibiotic-Antimycotic solution. Human mammary epithelial cells (HMEC) were purchased 
from Life technologies (Gibco® ) and grown in HUMEC serum-free medium supplemented with 20 μ g/mL of 
Antibiotic-Antimycotic solution (Life technologies, Gibco® ). All cells were incubated in a humidified atmosphere 
containing 5% CO2 and 95% air at 37 °C. Culture media was changed every 2 days and the cultures were passaged 
with 0.25% trypsin-EDTA (Life technologies, Gibco® ) when 80% of confluence was achieved.
Figure 6. (A) Linear discriminant analysis (LDA) scatter plot of cultured headspace from breast cell samples 
(B) Classification of breast cells according to the canonical discriminant functions. Legend: BL-breast luminal; 
N- normal; BTN- breast triple negative.
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VOC extraction from cell cultures. To extract VOCs from cell cultures, glass flasks were treated with 
collagen to promote cell adherence. Briefly, the glass flasks were covered with a collagen solution (0.2 mg/mL) 
for 30 min and then washed with PBS (3 times). The cells were then cultured in the T75 flasks for 48 h. After 
this period, volatile metabolites were extracted using a 50/30 μ m divinylbenzene/carboxen/polydimethylsiloxane 
(DVB/CAR/PDMS) SPME fiber exposed in the headspace of the flasks for 45 min at 37 °C, followed by injection 
into the GC injection port for 10 min to allow the desorption of VOCs from the fiber. After these extractions, 
cell-free aliquots were collected from the flasks holding 10 mL of the culture medium with growing cells. They 
were centrifuged to remove any suspended cells, and then 1 mL aliquots were adjusted to pH 2, 7 or 10 with 
1 M HCl or 1 M NaOH26. After the addition of 200 mg NaCl and subsequent stirring (0.5 mm × 0.1 mm bar) at 
800 rpm, the vials were capped with PTFE septa through which the SPME fiber was inserted in the headspace of 
the vial and placed in a thermostatic bath at 37 °C for 45 min. After this, the fiber was withdrawn into the needle 
and injected in the GC port (250 °C) over 10 min, when the analytes were thermally desorbed and transferred to 
the analytical column. Control headspace samples were also collected from flasks containing only empty media 
treated with the same incubation conditions to determine the contribution to the background. The analyses were 
performed in triplicate.
GC-MS analysis. VOCs in the headspace were analyzed using an Agilent Technologies 6890 N Network 
gas chromatograph system (Palo Alto, CA, USA) equipped with a BP-20 fused silica column (60 m × 0.25 mm 
I.D. × 0.25 μ m film thickness, SGE, Dortmund, Germany) interfaced with an Agilent 5975 quadrupole inert mass 
selective detector. The following oven temperature profile was set: (a) 5 min at 45 °C; (b) increase temperature 
until 150 °C, at a rate of 2 °C min−1 (hold for 10 min); (c) 150 °C for 10 min; (d) increase temperature until 220 °C, 
at a rate of 7 °C min−1; and (e) 220 °C for 10 min. Column flow was constant at 1.0 mL/min using helium (He, N60, 
Air Liquide, Portugal) as the carrier gas. The injection port was maintained at 250 °C and operated in the splitless 
mode. Regarding MS analyses, the operating temperatures of the transfer line, quadrupole and ionization source 
were 270, 150 and 230 °C, respectively. The electron impact mass spectra were recorded at 70 eV and the ioniza-
tion current was 10 μ A, and data acquisition was performed in scan mode (30–200 m/z). The identification of 
metabolites was performed comparing mass spectra with the Agilent MS ChemStation Software (Palo Alto, CA, 
USA) equipped with the NIST05 mass spectral library with a similarity threshold higher than 80%, or with com-
mercially standards when available. All experiments were performed in triplicate and the results were expressed 
as the mean ± standard deviation.
Statistical analysis. Statistical tests were performed using the StatSoft STATISTICA 12.0 (2013) software 
(Tulsa, OK, USA). Differences in VOCs between groups were tested with one-way ANOVA, and p < 0.05 was 
considered as statistically significant. PCA, PLS and LDA were carried out on VOCs selected by ANOVA to 
evaluate differences among the studied groups. PCA was performed in order to obtain differentiation between 
samples under study without classification and PLS was used as a supervised linear pattern recognition algorithm 
for data classification of samples. PCA and PLS were performed through variables values scale by unit standard 
deviation with convergence criterion (0.0001) and leave-one-out cross validation for accuracy confirmation. For 
LDA analysis a backward selection method was used with a p < 0.05 through Wilks test. For cross validation a 
leave-one-out strategy was used.
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